AGIO
AGIO
US00847X1046
Agios Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 54.028.000 36.498.000
48.0%
Cost of Revenue 6.345.000 4.165.000
52.3%
Gross Profit 47.683.000 32.333.000
47.5%
519.815.000 458.070.000
13.5%
Operating Income -472.132.000 -425.737.000
10.9%
Pretax Income -413.797.000 717.969.000
157.6%
Net Income Common Stockholders -412.781.000 673.725.000
161.3%
-- --
--
-- --
--
ende